chr3-69109135-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS1
The NM_198271.5(LMOD3):c.1657-14T>C variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000217 in 1,600,178 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0012 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00011 ( 1 hom. )
Consequence
LMOD3
NM_198271.5 splice_polypyrimidine_tract, intron
NM_198271.5 splice_polypyrimidine_tract, intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.64
Genes affected
LMOD3 (HGNC:6649): (leiomodin 3) The protein encoded by this gene is a member of the leiomodin family of proteins. This protein contains three actin-binding domains, a tropomyosin domain, a leucine-rich repeat domain, and a Wiskott-Aldrich syndrome protein homology 2 domain (WH2). Localization of this protein to the pointed ends of thin filaments has been observed, and there is evidence that this protein acts as a catalyst of actin nucleation, and is important to the organization of sarcomeric thin filaments in skeletal muscles. Mutations in this gene have been associated as one cause of Nemaline myopathy, as other genes have also been linked to this disorder. Nemaline myopathy is a disorder characterized by nonprogressive generalized muscle weakness and protein inclusions (nemaline bodies) in skeletal myofibers. Patients with mutations in this gene often present with a severe congenital form of the disorder. [provided by RefSeq, Jan 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 3-69109135-A-G is Benign according to our data. Variant chr3-69109135-A-G is described in ClinVar as [Benign]. Clinvar id is 1569757.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00123 (187/152308) while in subpopulation AFR AF= 0.00419 (174/41566). AF 95% confidence interval is 0.00368. There are 1 homozygotes in gnomad4. There are 88 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LMOD3 | NM_198271.5 | c.1657-14T>C | splice_polypyrimidine_tract_variant, intron_variant | ENST00000420581.7 | NP_938012.2 | |||
LMOD3 | NM_001304418.3 | c.1657-14T>C | splice_polypyrimidine_tract_variant, intron_variant | NP_001291347.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LMOD3 | ENST00000420581.7 | c.1657-14T>C | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_198271.5 | ENSP00000414670 | P1 | |||
LMOD3 | ENST00000475434.1 | c.1657-14T>C | splice_polypyrimidine_tract_variant, intron_variant | 5 | ENSP00000418645 | P1 | ||||
LMOD3 | ENST00000489031.5 | c.1657-14T>C | splice_polypyrimidine_tract_variant, intron_variant | 2 | ENSP00000417210 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00123 AC: 187AN: 152190Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
187
AN:
152190
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000273 AC: 61AN: 223114Hom.: 0 AF XY: 0.000232 AC XY: 28AN XY: 120438
GnomAD3 exomes
AF:
AC:
61
AN:
223114
Hom.:
AF XY:
AC XY:
28
AN XY:
120438
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000111 AC: 160AN: 1447870Hom.: 1 Cov.: 29 AF XY: 0.0000988 AC XY: 71AN XY: 718662
GnomAD4 exome
AF:
AC:
160
AN:
1447870
Hom.:
Cov.:
29
AF XY:
AC XY:
71
AN XY:
718662
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00123 AC: 187AN: 152308Hom.: 1 Cov.: 32 AF XY: 0.00118 AC XY: 88AN XY: 74478
GnomAD4 genome
AF:
AC:
187
AN:
152308
Hom.:
Cov.:
32
AF XY:
AC XY:
88
AN XY:
74478
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Nemaline myopathy 10 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 28, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at